Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex VirusHiroaki Uchida, Joseph C. Glorioso, Marco Marzulli et al.|Molecular Therapy|2012Cited by 117
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicityYoshitaka Miyagawa, Joseph C. Glorioso, Pietro Marino et al.|Proceedings of the National Academy of Sciences|2015Cited by 79
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas Denton, Timothy P. Cripe, Chun‐Yu Chen et al.|Molecular Therapy — Oncolytics|2018Cited by 56
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L. Leddon, Timothy P. Cripe, Chun‐Yu Chen et al.|Molecular Therapy — Oncolytics|2014Cited by 44
VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid CellsMark A. Currier, Timothy P. Cripe, Francis K. Eshun et al.|Molecular Therapy|2013Cited by 40